Christian Heidbreder
Chief Tech/Sci/R&D Officer presso INDIVIOR PLC
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Christian Heidbreder is currently the Chief Scientific Officer at Indivior PLC since 2014.
He is also a Professor at the Medical College of Virginia.
Previously, he worked as the Global Director-Research & Development at Reckitt Benckiser Pharmaceuticals, Inc. He completed his undergraduate, graduate, and doctorate degrees from the Université Catholique de Louvain.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
INDIVIOR PLC
0.07% | 06/03/2024 | 92 922 ( 0.07% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Christian Heidbreder
Società | Posizione | Inizio |
---|---|---|
INDIVIOR PLC | Chief Tech/Sci/R&D Officer | 01/12/2014 |
Medical College of Virginia | Corporate Officer/Principal | - |
Precedenti posizioni note di Christian Heidbreder
Società | Posizione | Fine |
---|---|---|
Reckitt Benckiser Pharmaceuticals, Inc.
Reckitt Benckiser Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA. | Corporate Officer/Principal | - |
Formazione di Christian Heidbreder
Université Catholique de Louvain | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
INDIVIOR PLC | Health Technology |
Aziende private | 1 |
---|---|
Reckitt Benckiser Pharmaceuticals, Inc.
Reckitt Benckiser Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA. | Health Technology |
- Borsa valori
- Insiders
- Christian Heidbreder